Haiqing Hua

机构：Cell Biologics (United States) · ORCID：0000-0002-1282-1215

发表论文 28 篇 · 总被引 515 次 · h-index 12

代表论文

• Acupuncture for cancer pain: an evidence-based clinical practice guideline (2022 · Chinese Medicine · 被引 71)
• A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China (2020 · Chinese Clinical Oncology · 被引 42)
• Ginsenoside Rg3 Combined with Oxaliplatin Inhibits the Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells <i>via</i> Downregulating PCNA and Cyclin D1 (2019 · Biological and Pharmaceutical Bulletin · 被引 37)
• Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic (2021 · Bioengineered · 被引 36)
• Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer (2022 · Journal of the National Cancer Center · 被引 28)
• DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models (2024 · Journal of Translational Medicine · 被引 22)